In human demyelinating diseases such as multiple sclerosis (MS), an imbalance between
demyelination and remyelination can trigger progressive degenerative processes. The …

Multiple Sclerosis (MS) is a neuroinflammatory disorder, which is histopathologically
characterized by multifocal inflammatory demyelinating lesions affecting both the central …

Multiple sclerosis is an autoimmune disease characterised by demyelination in the central
nervous system. The cuprizone-induced demyelination model is often used in mice to test …

A change in visual perception is a frequent early symptom of multiple sclerosis (MS), the
pathoaetiology of which remains unclear. Following a slow demyelination process caused …

Multiple sclerosis (MS), especially in its progressive phase, involves early axonal and
neuronal damage resulting from a combination of inflammatory mediators, demyelination …

The cuprizone model is a widely used model to study the pathogenesis of multiple sclerosis
(MS). Due to the selective loss of mature oligodendrocytes and myelin, it is mainly being …

Multiple sclerosis (MS) is one of the most common demyelinating diseases of the central
nervous system (CNS). While the exact cause of MS is unknown, it is considered to be an …

This thesis explored common mechanisms of oxidative damage in multiple sclerosis and
neurotrauma and encompasses work that has been published in four journal articles …

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the
central nervous system (CNS) characterized by demyelination of nerves, and neural …